CAS RN: 1610022-76-8

1-(4-(tert-butyl)benzyl)-3-(4-chlorophenyl)-N-hydroxy-1H-pyrazole-5-carboxamide

Product Availability

Choose a grade to view its available package options.

8 package records7 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250301 100mg In stock Shanghai Inquiry
Batchno.20260518 10mg In stock Shanghai Inquiry
Batchno.20250115 1mg In stock Shanghai Inquiry
Batchno.20250311 250mg In stock Shanghai Inquiry
Batchno.20250102 25mg In stock Shanghai Inquiry
Batchno.20260130 50mg In stock Shanghai Inquiry
Batchno.20250129 5mg In stock Shanghai Inquiry
Batchno.20260526 5mg / 25mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS1610022-76-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1610022-76-8 / 1-[(4-tert-butylphenyl)methyl]-3-(4-chlorophenyl)-N-hydroxypyrazole-5-carboxamide

Standard CAS: 1610022-76-8 Multi CAS: No

Basic Information

CAS
1610022-76-8
Multi CAS
No
Molecular Formula
C21H22ClN3O2
Molecular Weight
383.900000
Exact Mass
383.140055
SMILES
CC(C)(C)C1=CC=C(C=C1)CN2C(=CC(=N2)C3=CC=C(C=C3)Cl)C(=O)NO
InChI
InChI=1S/C21H22ClN3O2/c1-21(2,3)16-8-4-14(5-9-16)13-25-19(20(26)24-27)12-18(23-25)15-6-10-17(22)11-7-15/h4-12,27H,13H2,1-3H3,(H,24,26)
InChIKey
ZFDMUUNGVLREEC-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
27
Aromatic heavy atom count
17
Fraction Csp3
0.24
Rotatable bonds
4
H-bond acceptors
4
H-bond donors
2
Molar refractivity
106.17
TPSA
67.15

LogP / Solubility

WLOGP
4.67
MLOGP
4.13
XLogP3
4.9
Consensus LogP
4.57
Log S (ESOL)
-5.36
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.08
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.51
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.75

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us